Journal
JOURNAL OF SUBSTANCE USE & ADDICTION TREATMENT
Volume 156, Issue -, Pages -Publisher
ELSEVIER SCIENCE INC
DOI: 10.1016/j.josat.2023.209211
Keywords
Anxiety sensitivity; Dual use; Cannabis; Smoking cessation
Categories
Ask authors/readers for more resources
The integrated anxiety sensitivity smoking cessation intervention shows significant differences in long-term smoking abstinence among individuals who engage in dual cigarette and cannabis use, suggesting its clinical significance.
Introduction: Cannabis use among individuals who smoke is prevalent in the general population and related to adverse health effects, including higher levels of interoceptive perturbation (i.e., a disturbance in internal experiences). An important aspect of smoking cessation among individuals who co-use cannabis is to address behavioral associations between physiological sensations and habitual behaviors via integrated treatments focused on reducing reactivity to internal perturbations such as anxiety sensitivity (i.e., the belief that such symptoms produce personal harm). Methods: The current study involved a secondary analysis of a randomized clinical trial (RCT) of an integrated anxiety sensitivity-smoking cessation intervention compared to standard smoking cessation. The current study sought to extend findings from the initial trial to examine if the integrated intervention produced better smoking cessation outcomes than standard care among individuals who engage in dual cigarette and cannabis use. Participants were 149 adults who engage in dual cigarette and cannabis use (41.6 % female; Mage = 30.89, SD = 13.1). Results: Results indicated that the anxiety sensitivity intervention produced statistically significant differences in distal (long-term) smoking abstinence at 3-, 6-, and 12-month follow-up assessments but not proximal (shortterm; quit-week to 2-weeks) smoking abstinence. Conclusions: Overall, the potential of an integrated anxiety sensitivity smoking cessation intervention to yield better long-term smoking abstinence rates than standard cessation treatment among individuals who engage in dual cigarette and cannabis use is clinically significant.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available